ClinicalTrials.gg
CompletedNCT07948941Updated Nov 19, 2026

Initial Periodontal Therapy in Smokers and Non-smokers With Chronic Periodontitis

An interventional study of Initial periodontal therapy in Chronic Periodontitis, Generalized and Smoking ( Cigarette), sponsored by Marmara University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Marmara University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 10 years after the study started (first participant enrolled Nov 2016, registered Nov 2026).
Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Non-randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 26 studies in Chronic Periodontitis with a site in Turkey — 1 open to participants now, 1 under way, none of them phase 3. Chronic Periodontitis · Turkey.

Enrollment
5th of 15
40 · median 30
Started
2016
with 1 other
No phase
12 of 26
1 open now
Registered
26th of 26
by date
Lead sponsor
4 of 26
Marmara University

Among the 26 studies in Chronic Periodontitis with a site in Turkey, this one is the 5th largest by enrollment of the 15 interventional ones that give a count, is one of 2 that started in 2016, is one of 12 with no phase, and was the 26th registered.

Chronic Periodontitis

378 studies on the registry are indexed under Chronic Periodontitis; 21 are open to participants now.

Browse Chronic Periodontitis studies →

Open to participants now

1 of the 26 studies in Chronic Periodontitis with a site in Turkey is open now. Recruiting first, the newest first:

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 13 Chronic Periodontitis studies recruiting now, 7 (54%) set no upper age limit and 5 (38%) stop at 75 or younger; none take children under 18; 4 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Chronic Periodontitis with a site in Turkey, or all of them as a file.
02

Study summary

This study was conducted to evaluate the effect of initial periodontal treatment on clinical parameters, gingival crevicular fluid (GCF) volume, cotinine levels and tissue factor (TF) activity in saliva and GCF in smoker and non-smoker patients with chronic periodontitis. Forty systemically healthy patients with chronic periodontitis (20 smokers, 20 non-smokers) were included. Initial periodontal treatment consisting of oral hygiene instruction, scaling and root planing was applied. Clinical measurements were recorded and saliva and GCF samples were collected at baseline and 1 and 3 months after treatment.

Read the detailed description

Smoking is considered a major environmental risk factor for periodontitis and is known to impair the response to periodontal therapy. Cotinine, the main metabolite of nicotine, is regarded as a reliable biochemical marker of smoking status. Tissue factor (TF), the initiator of the extrinsic coagulation pathway, has been detected in saliva and is thought to contribute to hemostasis and the barrier function of the oral mucosa.

Patients diagnosed with chronic periodontitis according to the 1999 AAP classification were allocated into two groups according to smoking status: smokers (≥10 cigarettes/day for the last 5 years, n=20) and non-smokers (n=20). One day before treatment (day -1), plaque index (PI), gingival index (GI), probing depth (PD), clinical attachment level (CAL) and bleeding on probing (BOP) were recorded at six sites per tooth with a UNC-15 probe, and intraoral photographs were taken. On day 0, unstimulated saliva samples were collected, and GCF samples were obtained with paper strips from sites with PD ≥5 mm. GCF volume was determined by weighing. Oral hygiene instruction (modified Bass technique, dental floss/interdental brushes) was then given, and full-mouth supragingival scaling was performed. Subgingival scaling and root planing were carried out under local anesthesia with ultrasonic scalers and Gracey curettes, one quadrant per weekly session over 4 sessions. Clinical measurements and saliva/GCF sampling were repeated at 1 and 3 months. All measurements, sample collections and treatments were performed by the same investigator. TF activity was analyzed with the Quick method (clotting time), and cotinine levels were determined by competitive ELISA. Sample size was calculated based on a between-group GI difference of 0.3 (SD 0.2), with α=0.05 and 95% power; 12 patients per group were found to be required, and 20 patients per group were enrolled to allow for possible dropouts.

03

Conditions studied

  • Chronic Periodontitis, Generalized
  • Smoking ( Cigarette)

Keywords

  • scaling and root planing
  • tissue factor
  • cotinine
  • gingival crevicular fluid
  • saliva
  • non-surgical periodontal therapy
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of chronic periodontitis (1999 AAP classification): at least 3 sites with PD ≥5 mm and BOP, with radiographic bone loss
  • Systemically healthy
  • At least 20 teeth, in at least 2 quadrants
  • No anti-inflammatory, antibiotic or antimicrobial use within the last 3 months
  • No periodontal treatment within the last 6 months
  • Smokers: ≥10 cigarettes/day for the last 5 years
  • Non-smokers: never smoked or quit smoking at least 1 year ago

Exclusion criteria

Exclusion Criteria:

  • Pregnancy or lactation
  • Development of a systemic disease during the study
  • Need for antibiotics or antimicrobial agents during the study
  • Starting medication that affects periodontal tissues
  • Non-smokers starting to smoke during the study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Smokers

    Smoker patients with chronic periodontitis who received initial periodontal therapy.

    Procedure: Initial periodontal therapy

  • Active comparator
    Non-smokers

    Non-smoker patients with chronic periodontitis who received initial periodontal therapy.

    Procedure: Initial periodontal therapy

Interventions

  • ProcedureInitial periodontal therapy

    Oral hygiene instruction and full-mouth scaling and root planing performed with ultrasonic scalers and Gracey curettes under local anesthesia in 4 sessions.

06

What researchers measure

Primary outcomes

  1. Change in Gingival Index

    Time frame: baseline, 1 month, 3 months

Secondary outcomes

  1. Salivary cotinine (ng/ml)

    Time frame: baseline, 1 month, 3 months

  2. GCF cotinine (ng/ml)

    Time frame: baseline, 1 month, 3 months

  3. Salivary TF activity (clotting time, s)

    Time frame: baseline, 1 month, 3 months

  4. GCF TF activity (clotting time, s)

    Time frame: baseline, 1 month, 3 months

07

Study locations

1 site
  • Marmara University Faculty of Dentistry, Department of Periodontology
    Istanbul, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared, as data sharing was not included in the informed consent obtained from participants.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2016 to primary completion in May 2017, 5 months.

Of 89 non-industry interventional studies with no phase under Chronic Periodontitis, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 24. This study's 5 months is below that.

Counting every sponsor, half of 90 studies reached it within 15 months; a quarter within 10 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 15, 2026
First posted
Nov 19, 2026
StartActual
Nov 8, 2016
Primary completionActual
May 1, 2017
CompletionActual
May 1, 2017
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07948941
Lead sponsor
Marmara University
Responsible party
Sponsor
First posted
Nov 19, 2026
Start date
Nov 8, 2016
Primary completion
May 1, 2017
Completion
May 1, 2017
Last update
Nov 19, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion